EyePoint Pharmaceuticals Inc. buy Jefferies Financial Group Inc.
Start price
28.08.24
/
50%
€8.42
Target price
28.08.25
€13.50
Performance (%)
16.06%
End price
29.08.25
€9.77
Summary
This prediction ended on 29.08.25 with a price of €9.77. The prediction had a final performance of 16.06%. Jefferies_Financial_ has a follow-up prediction for EyePoint Pharmaceuticals Inc. where he still thinks EyePoint Pharmaceuticals Inc. is a Buy. Jefferies_Financial_ has 50% into this predictionPerformance without dividends (%)
| Name | 1w | 1m | 1y |
|---|---|---|---|
| EyePoint Pharmaceuticals Inc. | -2.564% | -2.564% | 26.667% |
| iShares Core DAX® | -0.874% | 5.325% | 6.865% |
| iShares Nasdaq 100 | -0.381% | 1.979% | 25.696% |
| iShares Nikkei 225® | -1.676% | 1.952% | 41.443% |
| iShares S&P 500 | -0.655% | 2.069% | 21.405% |
Comments by Jefferies_Financial_ for this prediction
In the thread EyePoint Pharmaceuticals Inc. diskutieren
EyePoint Pharmaceuticals, Inc. (NASDAQ: EYPT) is now covered by analysts at Jefferies Financial Group Inc.. They set a "buy" rating and a $15.00 price target on the stock.
Ratings data for EYPT provided by MarketBeat
In the thread Trading EyePoint Pharmaceuticals Inc.
Die von Jefferies_Financial_ gewählte maximale Laufzeit wurde überschritten
Current prediction by Jefferies_Financial_ for EyePoint Pharmaceuticals Inc.
EyePoint Pharmaceuticals Inc.
Start price
Target price
Perf. (%)
€4.06
17.08.26
17.08.26
€6.91
17.08.27
17.08.27
16.26%
14.08.26
14.08.26
